NECLIFE price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- NECLIFE
- MB Code
- MBEQU5511
- ISIN
- INE023H01027
- BSE code
- 532649
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 1.29 Cr
- Net profit
- -37.21 Cr
- EPS
- -3.38
- YoY revenue
- -99.70%
Company documents
9 PDFs across 3 categories
Audited annual reports & financial statements
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for NECLIFE
Nectar Lifescience posted a consolidated net loss of Rs 67.92 crore for the March 2026 quarter; full-year loss widened to Rs 292.89 crore…
Buyback up to ₹27 per share
Tender Offer · ₹81 Cr aggregate
Nectar Lifesciences shares surged 18% on December 4, 2025, following a ₹81-crore buyback announcement at a 51% premium. The buyback will …
Nectar Lifesciences shares fell 20% following the announcement of selling its core business for ₹1,270 crore, part of a strategy to strea…
Nectar Lifesciences sells its core API and formulation business for Rs 1290 crore, leading to a 20% stock crash. This business accounted …
Nectar Lifesciences shares fell to a 52-week low of ₹18.6, down 19.6% in trade, prompting investor concerns.
Nectar Lifesciences shares dropped nearly 20% to ₹18.60 after announcing the sale of its API and formulations business to Ceph Lifescienc…
Price returns
Historical performance
Technicals
Indicator consensus